Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Equity (Unaudited)

v3.22.2
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Total
Special Voting Preferred Stock
Common
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Balance at Dec. 31, 2020 $ 57,222,620 $ 20,405,219 $ 1,990 $ 94,086,433 $ (91,497) $ (57,179,525)
Balance, shares at Dec. 31, 2020   2,667,349 19,901,248      
Conversion of Exchangeable Shares to common stock $ (7,803,475) $ 102 7,803,373
Conversion of Exchangeable Shares to common stock, shares   (1,020,062) 1,020,062      
Settlement of convertible debt 8,467,500 $ 208 8,467,292
Settlement of convertible debt, shares   2,080,140      
Shares withheld for withholding taxes (333,847) $ 5 333,842
Shares withheld for withholding taxes, shares   48,948      
Stock-based compensation 503,379 503,379
Liabilities settled with shares 377,325 $ 10 377,315
Liabilities settled with shares, shares   101,705      
Restricted stock vesting $ 1 (1)
Restricted stock vesting shares   13,978      
Forfeitures of restricted shares
Forfeitures of restricted shares, shares   (668)      
Foreign currency translation adjustments (230) (230)
Unrealized (loss) gain on convertible notes (13,000) (13,000)
Net loss (6,457,702) (6,457,702)
Balance at Mar. 31, 2021 59,766,045 $ 12,601,744 $ 2,306 110,903,949 (104,727) (63,637,227)
Balance, shares at Mar. 31, 2021   1,647,287 23,067,517      
Balance at Dec. 31, 2020 57,222,620 $ 20,405,219 $ 1,990 94,086,433 (91,497) (57,179,525)
Balance, shares at Dec. 31, 2020   2,667,349 19,901,248      
Foreign currency translation adjustments 1,953          
Unrealized (loss) gain on convertible notes (16,000)          
Net loss (12,562,954)          
Balance at Jun. 30, 2021 61,962,363 $ 7,951,203 $ 2,533 123,856,649 (105,544) (69,742,478)
Balance, shares at Jun. 30, 2021   1,039,373 25,332,439      
Balance at Mar. 31, 2021 59,766,045 $ 12,601,744 $ 2,306 110,903,949 (104,727) (63,637,227)
Balance, shares at Mar. 31, 2021   1,647,287 23,067,517      
Conversion of Exchangeable Shares to common stock $ (4,650,541) $ 62 4,650,479
Conversion of Exchangeable Shares to common stock, shares   (607,914) 607,914      
Settlement of convertible debt 1,729,144 $ 54 1,729,090
Settlement of convertible debt, shares   543,355      
Shares withheld for withholding taxes (6,002,000) $ (100) (6,001,900)
Shares withheld for withholding taxes, shares   (1,000,000)      
Stock-based compensation 571,242 571,242
Liabilities settled with shares
Restricted stock vesting $ 11 (11)
Restricted stock vesting shares   114,321      
Forfeitures of restricted shares
Forfeitures of restricted shares, shares   (668)      
Foreign currency translation adjustments 2,183 2,183
Unrealized (loss) gain on convertible notes (3,000) (3,000)
Net loss (6,105,251) (6,105,251)
Balance at Jun. 30, 2021 61,962,363 $ 7,951,203 $ 2,533 123,856,649 (105,544) (69,742,478)
Balance, shares at Jun. 30, 2021   1,039,373 25,332,439      
Balance at Dec. 31, 2021 59,949,683 $ 2,366,038 $ 3,100 146,027,258 61,523 88,508,236
Balance, shares at Dec. 31, 2021   309,286 31,001,884      
Conversion of Exchangeable Shares to common stock $ (18,620) 18,620
Conversion of Exchangeable Shares to common stock, shares   (2,434) 2,434      
Settlement of convertible debt 3,300,000 $ 340 3,299,660
Settlement of convertible debt, shares   3,396,842      
Shares withheld for withholding taxes (5,615) 5,615
Shares withheld for withholding taxes, shares   4,421      
Shares returned in connection with 365 Cannabis acquisition (940,000) $ 28 939,972
Shares returned in connection with 365 Cannabis acquisition, Shares   279,762      
Stock-based compensation 316,855 316,855
Liabilities settled with shares 45,066 $ 1 45,065
Liabilities settled with shares, shares   14,632      
Restricted stock vesting $ 4 (4)
Restricted stock vesting shares   43,479      
Foreign currency translation adjustments (33,800) (33,800)
Unrealized (loss) gain on convertible notes 101,000 101,000
Net loss (21,952,893) (21,952,893)
Balance at Mar. 31, 2022 $ 40,780,296 2,347,418 $ 3,417 148,761,867 128,723 (110,461,129)
Balance, shares at Mar. 31, 2022 306,852   34,175,088      
Balance at Dec. 31, 2021 $ 59,949,683 $ 2,366,038 $ 3,100 146,027,258 61,523 88,508,236
Balance, shares at Dec. 31, 2021   309,286 31,001,884      
Foreign currency translation adjustments (23,171)          
Unrealized (loss) gain on convertible notes 264,000          
Net loss (51,518,840)          
Balance at Jun. 30, 2022 12,945,012 $ 2,227,619 $ 3,680 150,438,437 302,352 (140,027,076)
Balance, shares at Jun. 30, 2022   291,192 36,826,733      
Balance at Mar. 31, 2022 $ 40,780,296 $ 2,347,418 $ 3,417 148,761,867 128,723 (110,461,129)
Balance, shares at Mar. 31, 2022 306,852   34,175,088      
Conversion of Exchangeable Shares to common stock $ 119,799 119,797
Conversion of Exchangeable Shares to common stock, shares   15,660 15,660      
Settlement of convertible debt 625,500 $ 75 625,425
Settlement of convertible debt, shares   751,686      
Shares withheld for withholding taxes (7,552) (7,552)
Shares withheld for withholding taxes, shares   (6,743)      
Shares returned in connection with 365 Cannabis acquisition (761,178) $ (182) (760,996)
Shares returned in connection with 365 Cannabis acquisition, Shares   (1,816,184)      
Stock-based compensation 148,444 148,444
Liabilities settled with shares 4,464 4,463
Liabilities settled with shares, shares     14,632      
Restricted stock vesting 25,000 $ 3 24,997
Restricted stock vesting shares     60,226      
Foreign currency translation adjustments 10,629 10,629
Unrealized (loss) gain on convertible notes 163,000 163,000
Net loss (29,565,947) (29,565,947)
Balance at Jun. 30, 2022 $ 12,945,012 $ 2,227,619 $ 3,680 $ 150,438,437 $ 302,352 $ (140,027,076)
Balance, shares at Jun. 30, 2022   291,192 36,826,733